You are here

IPF

FibroGen plans new round of cost cuts after latest study setback

FibroGen plans new round of cost cuts after latest study setback

BioPharma Dive

clinical trials

Flag link:

First Human Trials Begin for AI-Designed Drug

First Human Trials Begin for AI-Designed Drug

The Daily Upside

clinical trials

artificial intelligence

Flag link:

Late-stage pipeline for idiopathic pulmonary fibrosis is small but growing

Late-stage pipeline for idiopathic pulmonary fibrosis is small but growing

Clinical Trials Arena

Boehringer Ingelheim

Flag link:

Bridge doses first patient in Phase lla trial of IPF therapy

Bridge doses first patient in Phase lla trial of IPF therapy

Clinical Trials Arena

Bridge Biotherapeutics

clinical trials

Flag link:

Promising IPF treatment results sent Pliant Therapeutics stock soaring

Promising IPF treatment results sent Pliant Therapeutics stock soaring

Investors Business Daily

Pliant Therapeutics

clinical trials

Flag link:

Digital therapeutic cuts IPF-related anxiety by half in pilot study

Digital therapeutic cuts IPF-related anxiety by half in pilot study

Pharmaphorum

Alex Therapeutics

digital therapeutics

Flag link:

With new data, Pliant drug shows promise in tough-to-treat lung disease

With new data, Pliant drug shows promise in tough-to-treat lung disease

BioPharma Dive

Pliant Therapeutics

idiopathic pulmonary fibrosis

clinical trials

Flag link:

Roche comes up short in its attempt to hold off generic competition to Esbriet

Roche comes up short in its attempt to hold off generic competition to Esbriet

Endpoints

Flag link:

The lung fibrosis pipeline thins

The lung fibrosis pipeline thins

EP Vantage

idiopathic pulmonary fibrosis

Pliant Therapeutics

Flag link:

Liminal stops plan to advance fibrosis drug after seeing PK data

Liminal stops plan to advance fibrosis drug after seeing PK data

Fierce Biotech

Liminal BioSciences

clinical trials

Flag link:

Gilead's $5B Galapagos black hole widens as pair toss out phase 3 asset after flop

Gilead's $5B Galapagos black hole widens as pair toss out phase 3 asset after flop

Fierce Biotech

Gilead Sciences

Flag link:

With patent concerns looming, Roche gets a new priority review on blockbuster IPF drug

With patent concerns looming, Roche gets a new priority review on blockbuster IPF drug

Endpoints

priority review

Flag link:

Citing toxicity concerns, Boehringer Ingelheim drops short-lived IPF pact — keeping $1B+ in its pocket

Citing toxicity concerns, Boehringer Ingelheim drops short-lived IPF pact — keeping $1B+ in its pocket

Endpoints

Boehringer Ingelheim

Bridge Biotherapeutics

Flag link:

Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward

Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward

Xconomy

Galecto Biotech

idiopathic pulmonary fibrosis

Flag link:

Redx shares soar after IPF drug license deal with AstraZeneca

Redx shares soar after IPF drug license deal with AstraZeneca

Pharmaforum

Flag link:

Boehringer debuts IPF songwriting contest with MLB player-turned-singer Bernie Williams

Boehringer debuts IPF songwriting contest with MLB player-turned-singer Bernie Williams

Fierce Pharma

Boehringer Ingelheim

Flag link:

Lax Approval Requirements Yield Blockbusters That Don’t Work

Lax Approval Requirements Yield Blockbusters That Don’t Work

Xconomy

conditional approvals

Flag link:

Boehringer Ingelheim's Ofev nabs FDA nod for expanded use in rare lung disease

Boehringer Ingelheim's Ofev nabs FDA nod for expanded use in rare lung disease

Fierce Pharma

Boehringer Ingelheim

Flag link:

With one rival down, Novartis-partnered biotech scores $100M round to fund mid-stage trials of fibrosis drug

With one rival down, Novartis-partnered biotech scores $100M round to fund mid-stage trials of fibrosis drug

Endpoints

Pliant Therapeutics

Flag link:

Biogen stops Phase 2 study in another hit to 'high-risk' pipeline

Biogen stops Phase 2 study in another hit to 'high-risk' pipeline

Biopharma Dive

clinical trials

idiopathic pulmonary fibrosis

Flag link:

Pages